Skip to main content

Currently Skimming:

Appendix C: Workshop Agenda
Pages 99-104

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.

From page 99...
... Centers for Disease Control and Prevention Ben Nemser, Steven & Alexandra Cohen Foundation 99
From page 100...
... RECOVER Harlan Krumholz, Yale School of Medicine Hannah Davis, Patient-Led Research Collaborative Meghan O'Rourke, Yale University Author of The Invisible Kingdom: Reimagining Chronic Illness Q&A 10:00–10:15 a.m. BREAK 10:15 a.m.– Session 2: Common mechanistic factors of infection12:00 p.m.
From page 101...
... Moderator: Brian Fallon, Columbia University Effect of inflammation on the brain: Significance for chronic illnesses Andrew Miller, Emory University Role of the microbiome in ME/CFS Julia Oh, The Jackson Laboratory Pathogen-mediated factors and pathogen persistence Viral persistence and development of chronic illness: Lessons from Epstein-Barr virus (EBV) Bill Robinson, Stanford University Pathogen distribution and persistence: Learnings from SARS-CoV-2 Dan Chertow, NIH Modeling pathogen persistence: Lessons from animal studies Monica Embers, Tulane University Q&A
From page 102...
... Chan School of Public Health Microclots as a common indicator of chronic disease Resia Pretorius, Stellenbosch University Next-generation and metagenomic sequencing Charles Chiu, University of California, San Francisco Q&A 4:45–5:00 p.m. Synthesis and adjourn Amy Proal, PolyBio Research Foundation END OF DAY 1 Day 2: Clinical Advancements and Collaboration 8:30–9:00 a.m.
From page 103...
... BREAK 10:30 a.m.– Session 6: Research innovation and required 12:00 p.m. infrastructures Moderator: Tim Endy, CEPI Diagnostic journeys of long COVID patients Linda Geng, Stanford University Ultrasensitive diagnostic assays: Examples with SARS CoV-2 and long COVID David Walt, Harvard University Translating infection-associated chronic illnesses research into the clinic in drug repurposing Steven Deeks, University of California, San Francisco Treatment approaches to posttreatment Lyme disease and a new clinical trials network Brian Fallon, Columbia University Q&A 12:00–1:00 p.m.
From page 104...
... Session 8: Developing a shared research agenda: Challenges and opportunities Moderators: Avindra Nath, NINDS, NIH Amy Proal, PolyBio Research Foundation Lorraine Johnson, MyLymeData Peter Rowe, Johns Hopkins University Q&A 3:50–4:00 p.m. Synthesis and close Tim Endy, CEPI Tim Coetzee, National Multiple Sclerosis Society Workshop Cochairs END OF WORKSHOP

This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.